Project Updates
Orano Med’s Alpha Therapy Laboratory
Credit: Dmitry Kalinovsky / Shutterstock
Location: Onnaing, France
Project type: Manufacturing facility
Estimated Investment: €29m ($31m)
Construction started: February 2024
Orano Med, a US-based biotechnology company, will build a new Alpha Therapy Laboratory in Onnaing, France. It will be the first industrial-scale pharmaceutical manufacturing facility in Europe dedicated to producing the lead-212 radioligand therapies known as targeted alpha therapies (TAT).
Astellas Pharma Manufacturing Facility
Credit: Astellas Pharma
Location: County Kerry, Ireland
Project type: Manufacturing facility
Estimated Investment: €330m ($354m)
Construction started: March 2024
Astellas Pharma will establish a new manufacturing facility in Tralee in County Kerry, Ireland, to expand the ability to produce aseptic drug products and bolster stable production for worldwide distribution. The facility will be built as a three-story structure, covering a total floor area of 17,000m² (182,986ft²).
Evonik’s Lipid Production Facility
Credit: Evonik Industries
Location: Lafayette, Indiana, US
Project type: Lipid production facility
Estimated Investment: $220m
Construction started: September 2023
German speciality chemical company Evonik will build a highly flexible, global-scale pharmaceutical lipids production plant named Lipid Innovation Center in Lafayette, Indiana, in partnership with the US Government for manufacturing novel messenger RNA (mRNA)-based therapies in the US.
